Dimensional Fund Advisors LP increased its position in shares of Paysign, Inc. (NASDAQ:PAYS - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 267,899 shares of the company's stock after purchasing an additional 90,702 shares during the period. Dimensional Fund Advisors LP owned approximately 0.50% of Paysign worth $809,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Renaissance Technologies LLC boosted its holdings in shares of Paysign by 11.0% in the fourth quarter. Renaissance Technologies LLC now owns 1,501,622 shares of the company's stock valued at $4,535,000 after purchasing an additional 149,200 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Paysign by 164.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 63,247 shares of the company's stock worth $232,000 after buying an additional 39,299 shares during the period. Marshall Wace LLP bought a new position in shares of Paysign during the 4th quarter worth $489,000. Virtu Financial LLC purchased a new position in shares of Paysign during the fourth quarter valued at $78,000. Finally, SG Americas Securities LLC increased its stake in shares of Paysign by 33.5% during the fourth quarter. SG Americas Securities LLC now owns 15,508 shares of the company's stock valued at $47,000 after buying an additional 3,895 shares during the period. 25.89% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have issued reports on the stock. Barrington Research reiterated an "outperform" rating and set a $7.00 target price on shares of Paysign in a report on Wednesday, March 26th. Lake Street Capital increased their price objective on shares of Paysign from $6.00 to $7.00 and gave the company a "buy" rating in a research note on Friday, May 9th. LADENBURG THALM/SH SH lifted their price objective on shares of Paysign from $7.25 to $8.25 and gave the company a "buy" rating in a report on Friday, May 9th. Finally, DA Davidson upped their target price on Paysign from $5.00 to $6.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th.
Read Our Latest Stock Report on PAYS
Paysign Trading Down 1.4%
Shares of NASDAQ:PAYS traded down $0.05 during trading on Tuesday, reaching $3.58. The stock had a trading volume of 159,310 shares, compared to its average volume of 210,668. The firm's 50-day simple moving average is $2.39 and its 200 day simple moving average is $2.81. Paysign, Inc. has a one year low of $1.80 and a one year high of $5.59. The company has a market capitalization of $194.10 million, a P/E ratio of 23.87 and a beta of 0.23.
Paysign (NASDAQ:PAYS - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.04 by $0.01. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The firm had revenue of $18.60 million during the quarter, compared to analyst estimates of $17.49 million. Equities research analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.
Insider Activity
In related news, CEO Mark Newcomer sold 100,000 shares of Paysign stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $2.73, for a total transaction of $273,000.00. Following the completion of the sale, the chief executive officer now owns 8,936,886 shares of the company's stock, valued at $24,397,698.78. The trade was a 1.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 22.40% of the company's stock.
Paysign Company Profile
(
Free Report)
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Featured Stories

Before you consider Paysign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paysign wasn't on the list.
While Paysign currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.